NCT05943730

Brief Summary

Physical fitness levels of people waiting for a planned operation are often measured using an exercise test. This is because fitness levels help doctors make a plan to improve each person's chances of a successful recovery after their planned operation. The exercise test requires skilled staff, expensive equipment, a 1 hour appointment, and the patient to exercise heavily during the test. Ventriject, a small to medium sized enterprise, have designed a device called Seismofit that estimates fitness levels of people from a measurement taken whilst laying down. It measures the vibrations of the chest wall caused by the beating heart and uses this information with additional information, such as height, weight and sex, to estimate fitness. The measurement takes around 5 minutes to perform, does not require heavy exercise, expensive equipment or skilled staff. The Seismofit device was shown to be accurate in young fairly fit people. It has not been tested in people who undergo an exercise test before an operation, who are less fit on average compared to the people that the device was originally tested on. It is likely that the calculations used to estimate fitness levels with the Seismofit device will need to be adjusted for people waiting for an operation. There are two parts to this study. The first part aims to estimate up to 50 people's fitness with the Seismofit device and use directly measured fitness from their standard exercise test before their operation to adjust the calculations for estimating fitness. The second part of this study aims to have a further 50 people undergo the Seismofit device measurement and compare the estimated fitness level with the results from the standard exercise test before an operation. This is to see if the Seismofit device is valid at estimating fitness in people awaiting surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
143

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

August 31, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

March 6, 2024

Status Verified

June 1, 2023

Enrollment Period

11 months

First QC Date

July 4, 2023

Last Update Submit

March 4, 2024

Conditions

Keywords

SeismocardiographyPreoperative ExercisePeak oxygen uptakeVO2maxCardiopulmonary exercise test

Outcome Measures

Primary Outcomes (2)

  • Phase 1 outcome - refine algorithm

    Up to 50 patients awaiting major surgery will have their estimated V̇O2peak (ml/kg/min) recorded using the Seismofit device and actual V̇O2peak (ml/kg/min) measured in their standard preoperative cardiopulmonary exercise test. The Seismofit algorithm will be adjusted using these data points with machine learning.

    Up to 6 months

  • Phase 2 outcome - validity of refined algorithm

    The correlation between the new seismofit algorithm estimate of V̇O2peak (ml/kg/min) and CPET measured and verified V̇O2peak (ml/kg/min) in up to 50 preoperative patients that have valid tests in accordance with maximal exercise test criteria stated in the protocol (RER \> 1.10 or maximum heart rate attained within 10 beats of predicted maximum).

    12 months

Secondary Outcomes (2)

  • Bland-Altman analysis

    12 months

  • Existing V̇O2peak predicted equation analysis

    12 months

Other Outcomes (1)

  • Seismofit total population analysis

    12 months

Study Arms (1)

Seismofit Validity

EXPERIMENTAL

Participants will undergo a seismocardiography assessment, whilst supine, using the seismofit device. This will estimate their peak oxygen consumption. Participants will then undergo a maximal cardiopulmonary exercise test (CPET), where peak oxygen consumption will be measured. The Seismofit estimated peak oxygen consumption will be compared with CPET measured peak oxygen consumption (unless prespecified criteria for a maximal exercise test are not met).

Device: Seismofit

Interventions

SeismofitDEVICE

The Seismofit device uses seismocardiography to estimate peak oxygen consumption from a resting measurement. This study will assess its validity against the gold standard measure of peak oxygen consumption, cardiopulmonary exercise test, conducted as part of standard care.

Seismofit Validity

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults awaiting major or complex elective surgery classified by the NICE NG45 guideline
  • Referred for and capable of performing a maximum effort CPET as part of standard care within their preoperative assessment
  • Able to be fully supine for 5 minutes

You may not qualify if:

  • Pacemaker, implantable defibrillator, or any other implantable electronic device in situ
  • Permanent Atrial fibrillation, or other persistent arrhythmia (such as, atrial flutter, bigeminy, trigeminy, frequent premature atrial/ventricular complexes, 2nd degree heart block) documented in the patient's medical history
  • Body mass index (BMI) \>35 kg.m-2
  • Severe COPD (defined as FEV1 % predicted \<50% \[GOLD report, 2022\])
  • Pectus excavatum or other chest wall deformity
  • Claudication that limits exercise tolerance
  • Unable to perform maximal CPET
  • Refusal to give informed consent
  • Presence of an absolute contraindication to CPET detailed in the POETTS clinical guideline (Levett et al. 2018).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

South Tees Hospitals NHS Foundation Trust

Middlesbrough, United Kingdom

RECRUITING

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, United Kingdom

RECRUITING

York and Scarborough NHS Foundation Trust

York, United Kingdom

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2023

First Posted

July 13, 2023

Study Start

August 31, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

March 6, 2024

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations